Dose–response evaluation of the therapeutic index for inhaled budesonide in patients with mild-to-moderate asthma
- 1 March 2000
- journal article
- clinical trial
- Published by Elsevier in American Journal Of Medicine
- Vol. 108 (4), 269-275
- https://doi.org/10.1016/s0002-9343(99)00435-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Effect of Inhaled Budesonide on Lung Function and Airway InflammationAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Dose Response to Inhaled Corticosteroids: Benefits and RisksSeminars in Respiratory and Critical Care Medicine, 1998
- Measuring exhaled nitric oxide: not only a matter of how--but also why--should we do it?European Respiratory Journal, 1998
- Measurement of airway hyperresponsiveness: new considerationsThorax, 1998
- Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma.Thorax, 1998
- Adenosine bronchoprovocation: a promising marker of allergic inflammation in asthma?Thorax, 1997
- Measures for detecting systemic bioactivity with inhaled and intranasal corticosteroidsThorax, 1997
- Relationship between Activated Eosinophils of the Bronchial Mucosa and Serum Eosinophil Cationic Protein in Atopic AsthmaInternational Archives of Allergy and Immunology, 1997
- Serum eosinophil cationic protein (ECP) in chronic asthma. Relationship to spirometry, flow-volume curves, PC20, and exacerbationsRespiratory Medicine, 1994
- Bioequivalent doses of budesonide and prednisone in moderate and severe asthmaJournal of Allergy and Clinical Immunology, 1989